EDGAR Filing Documents for 0001171843-15-003261

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001171843-15-003261

Filing Date

2015-06-02

Accepted

2015-06-02 17:43:27

Documents

Period of Report

2015-05-29

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	gff4_060215oconnell.html	4
1	OWNERSHIP DOCUMENT	gff4_060215oconnell.xml	4	3847
	Complete submission text file	0001171843-15-003261.txt		5067

Mailing Address

Business Address

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 15908098

Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814

Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400

Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations